In Canada, the first death case was recorded due to the formation of thrombus vaccine vessels against coronavirus developed by the British-Swedish company Astrazeneca together with the University of Oxford. It is reported by CBC TV channel.
As the National Health Director of Quebec Oracio Arruday told, we are talking about a local resident who received the drug in early April. It has formed a thrombus in large vessels due to blood clotting disorders after Astrazeneca vaccination. In turn, the Minister of Health of Canada Christian Dyuba told about investigating three more cases of blood clots in the vaccinated vaccine.
On April 23, it was reported that in the UK for the week almost twice the number of people who had thrombus formed after the introduction of the Astrazenec vaccine. The number of such patients reached 168 people. At the same time, the British regulator, in turn, urged to continue the vaccine campaign of the Astrazeneca vaccine, since its benefits exceeded, as previously stated, “exceeds any risks.”
Some countries of Europe have suspended or banned vaccination with Astrazeneca due to discovery of thrombosis in the pregnant patients. Meanwhile, the creators of the vaccine insist on its safety. The company stated that a detailed study of the health of more than 17 million people after vaccination showed the absence of data on increased risk of pulmonary artery embolism, deep veins thrombosis or thrombocytopenia.